Written Question: The negotiations on advanced purchase agreements with Novavax and Valneva
(Source: European Parliament)
Date submitted: 23 March 2021
Question for written answer E-001604/2021
to the Commission
Juozas Olekas (S&D)
Subject: The negotiations on advanced purchase agreements with Novavax and Valneva
Earlier in 2021, the Commission announced negotiations on advanced purchase agreements with two more vaccine manufacturers: Novavax and Valneva.
Given the uncertainties related to the previously concluded contracts with other vaccine manufacturers, and given the facts that Valneva is a European manufacturer that provides the unique inactivated vaccine technology and that Novavax is in the final stage of its trials:
When will the Commission announce the final agreements on these contracts?